Novasign was founded in 2019 by people who strongly believe that process modeling is a key element for bringing biopharmaceuticals earlier to the market and reduce treatment costs. With this vision, we work on bringing modeling solutions to the industry to better understand, optimize, and accelerate the development of bioprocesses.
We are a team of hybrid modelers, bioprocess and automation engineers.
Together with Novasign's advisory board, we developed the first hybrid modeling toolbox for bioprocess applications and advise our customers on hybrid modeling and model-based process development.
get to know us more
Partners and co-operations
Strong products need reliable partners. The expertise of our partners, in automation of industrial processes, control systems, and business development, form an important cornerstone for Novasign's success.